Tonghua Dongbao Stock Soars 5.83%, Hits Intraday High of CNY 8.92

Tonghua Dongbao Pharmaceutical Co., Ltd. has experienced a notable surge in its stock performance, gaining 5.83% on March 27, 2026. The stock reached an intraday high of CNY 8.92, reflecting strong market activity. This performance stands in contrast to the China Shanghai Composite, which only increased by 0.63% on the same day. Over the past week, Tonghua Dongbao has shown a positive trend with a 3.49% increase, while the broader market has faced a decline of 1.09%. Year-to-date, the stock has risen by 8.94%, significantly outperforming the Shanghai Composite, which has seen a decrease of 1.39%. The company has reported impressive financial metrics, including a remarkable 806.57% growth in net profit as of September 25, 2025. Additionally, it achieved its highest operating cash flow of CNY 655.81 million and a return on capital employed (ROCE) of 18.09%. With a market capitalization of CNY 17,426 million, Tonghua Dongbao continues to solidify its position within the pharmaceuticals and biotechnology sector.